NYSE:MTNB

Matinas Biopharma Holdings Stock Insider Trading

etoro logo Buy MTNB
*Your capital is at risk
$0.294
-0.0236 (-7.44%)
At Close: Jul 31, 2026

Matinas Biopharma Holdings Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 80.16M and sold 0 MTNB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 80.16M shares
Sell 0 shares
100% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 11, 2025
Buy
Common Stock
J-Other
Murphy Keith
Director 0
Value: $0
Feb 13, 2025
Buy
Common Stock
Stern Adam K
10 Percent Owner
10% Owner 0
Value: $0
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Stern Adam K
10 Percent Owner
10% Owner 2 399 318
Value: $1.44M
Feb 13, 2025
Buy
Warrants
Stern Adam K
10 Percent Owner
10% Owner 4 798 636
Value: $2.88M
Feb 13, 2025
Buy
Warrants
Stern Adam K
10 Percent Owner
10% Owner 4 798 636
Value: $2.88M
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Stern Adam K
10 Percent Owner
10% Owner 2 399 318
Value: $1.44M
Feb 13, 2025
Buy
Common Stock
Stern Adam K
10 Percent Owner
10% Owner 0
Value: $0
Feb 13, 2025
Buy
Common Stock
Eide Robert J
10 Percent Owner
10% Owner 0
Value: $0
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Eide Robert J
10 Percent Owner
10% Owner 839 591
Value: $503.8K
Feb 13, 2025
Buy
Warrants
Eide Robert J
10 Percent Owner
10% Owner 1 679 182
Value: $1.01M
Feb 13, 2025
Buy
Warrants
Eide Robert J
10 Percent Owner
10% Owner 1 679 182
Value: $1.01M
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Eide Robert J
10 Percent Owner
10% Owner 839 591
Value: $503.8K
Feb 13, 2025
Buy
Common Stock
Eide Robert J
10 Percent Owner
10% Owner 0
Value: $0
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Sanitam Partners Llc
10 Percent Owner
10% Owner 1 199 659
Value: $719.8K
Feb 13, 2025
Buy
Warrants
Sanitam Partners Llc
10 Percent Owner
10% Owner 2 399 318
Value: $1.44M
Feb 13, 2025
Buy
Warrants
Sanitam Partners Llc
10 Percent Owner
10% Owner 2 399 318
Value: $1.44M
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Sanitam Partners Llc
10 Percent Owner
10% Owner 1 199 659
Value: $719.8K
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Pembroke & Partners Llc
10 Percent Owner
10% Owner 839 591
Value: $503.8K
Feb 13, 2025
Buy
Warrants
Pembroke & Partners Llc
10 Percent Owner
10% Owner 1 679 182
Value: $1.01M
Feb 13, 2025
Buy
Warrants
Pembroke & Partners Llc
10 Percent Owner
10% Owner 1 679 182
Value: $1.01M
Feb 13, 2025
Buy
Series C Convertible Preferred Stock
Pembroke & Partners Llc
10 Percent Owner
10% Owner 839 591
Value: $503.8K
Feb 13, 2025
Buy
Common Stock
J-Other
Smith Robin L
Director 0
Value: $0
Feb 13, 2025
Buy
Common Stock
J-Other
Smith Robin L
Director 0
Value: $0
Feb 05, 2025
Buy
Common Stock
J-Other
D An Evelyn
Director 0
Value: $0
Feb 05, 2025
Buy
Common Stock
J-Other
D An Evelyn
Director 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MATINAS BIOPHARMA HOLDINGS INC
Matinas Biopharma Holdings
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is LYPDISO, a presc...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE